Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?
Mineralys Therapeutics Ownership Summary
Mineralys Therapeutics is owned by 120.87% institutional investors, 0.67% insiders. Catalys pacific is the largest institutional shareholder, holding 9.54% of MLYS shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.14% of its assets in Mineralys Therapeutics shares.
MLYS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mineralys Therapeutics | 120.87% | 0.67% | -21.54% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Catalys pacific | 7.90M | 9.54% | $213.25M |
| Ra capital management | 7.69M | 9.29% | $207.55M |
| Blackrock funding, inc. /de | 5.89M | 7.11% | $158.83M |
| Samsara biocapital | 5.87M | 7.09% | $158.40M |
| Fmr | 4.51M | 5.45% | $121.73M |
| State street | 4.14M | 5.00% | $111.74M |
| Deerfield management company, l.p. (series c) | 3.96M | 4.78% | $106.79M |
| Vanguard group | 3.35M | 4.75% | $121.68M |
| Vanguard capital management | 2.76M | 3.33% | $74.38M |
| Laurion capital management lp | 2.51M | 3.03% | $67.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Catalys pacific | 7.90M | 92.94% | $213.25M |
| Andera partners | 1.59M | 20.80% | $42.95M |
| Samsara biocapital | 5.87M | 13.01% | $158.40M |
| Sphera funds management | 1.47M | 5.17% | $39.66M |
| Troluce capital advisors | 1.73M | 4.80% | $46.64M |
| Sr one capital management, lp | 1.56M | 4.06% | $42.20M |
| Davern capital partners, lp | 858.75K | 3.95% | $23.17M |
| Catalio capital management, lp | 648.72K | 3.29% | $17.50M |
| 22nw, lp | 113.84K | 2.93% | $3.07M |
| Stempoint capital lp | 602.69K | 2.80% | $16.26M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 3.96M | 1.11% | 3.96M |
| Capital world investors | 2.00M | 0.01% | 1.60M |
| Blackrock funding, inc. /de | 5.89M | 0.00% | 1.41M |
| State street | 4.14M | 0.00% | 1.21M |
| Ghisallo capital management | 1.13M | 0.60% | 1.13M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Caligan partners lp | - | - | -2.77M |
| Wellington management group llp | 806.72K | 0.00% | -2.55M |
| Tcg crossover management | - | - | -2.47M |
| Point72 asset management | - | - | -1.91M |
| Holocene advisors, lp | - | - | -1.60M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deerfield management company, l.p. (series c) | 3.96M | 1.11% | 3.96M | $106.79M |
| Ghisallo capital management | 1.13M | 0.60% | 1.13M | $30.35M |
| Logos global management lp | 1.05M | 1.22% | 1.05M | $28.33M |
| Abrdn | 689.24K | 0.03% | 689.24K | $18.60M |
| Sixth street partners management company | 521.22K | 0.00% | 521.22K | $14.06M |
Sold Out
| Holder | Change |
|---|---|
| Jpl wealth management | -3.00 |
| Quadrant capital group | -5.00 |
| Clearstead advisors | -11.00 |
| Skopos labs | -26.00 |
| Golden state wealth management | -32.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 239 | 4.37% | 100,122,304 | 10.85% | 120 | 0.68% | 120 | -9.77% | 71 | 36.54% |
| Mar 31, 2026 | 72 | -69.75% | 10,534,267 | -88.08% | 15 | 0.10% | 40 | -70.59% | 18 | -75.34% |
| Dec 31, 2025 | 143 | -28.50% | 40,919,125 | -48.50% | 57 | 0.39% | 86 | -23.89% | 44 | -29.03% |
| Sep 30, 2025 | 193 | 15.57% | 76,304,723 | 16.16% | 116 | 1.16% | 109 | -9.17% | 59 | 118.52% |
| Jun 30, 2025 | 166 | 3.75% | 65,673,217 | 7.91% | 100 | 0.77% | 119 | 9.17% | 27 | -3.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.77M | 3.14% | 6.36K |
| Vanguard Health Care Inv | 1.86M | 2.25% | 1.86M |
| Vanguard Total Stock Mkt Idx Inv | 1.97M | 2.23% | 189.02K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.97M | 2.23% | 189.02K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.97M | 2.23% | - |
| American Funds SMALLCAP World A | 1.94M | 2.21% | 1.55M |
| iShares Russell 2000 ETF | 1.46M | 1.66% | -26.02K |
| Polar Capital Biotech S Inc | 1.35M | 1.53% | - |
| Fidelity Select Health Care | 1.18M | 1.34% | - |
| HBM Healthcare Investments AG Ord | 1.14M | 1.29% | 355.43K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Warren Eric | Chief Commercial Officer | Sell | $193.19K |
| Aug 10, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $58.79K |
| Jul 21, 2026 | Warren Eric | Chief Commercial Officer | Sell | $199.89K |
| Jul 17, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $11.04K |
| Jul 13, 2026 | Congleton Jon | Chief Executive Officer | Sell | $291.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 7 |
| 2026 Q2 | - | 17 |
| 2026 Q1 | 2 | 27 |
| 2025 Q4 | - | 28 |
| 2025 Q3 | 2 | 10 |
MLYS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools